#inflammatory bowel disease

Indiana University researchers discovered that age-related blood mutations may drive severe inflammatory bowel disease, identifying a potential new drug target for Crohn's and colitis.

Researchers at Örebro University have identified anti-integrin αvβ6 antibodies in blood samples that can flag individuals at risk of developing ulcerative colitis long before any symptoms manifest. The discovery could enable earlier interventions and potentially delay the onset of this debilitating inflammatory bowel disease.